CTMX
Price
$2.11
Change
+$0.05 (+2.43%)
Updated
Sep 23 closing price
Capitalization
347.97M
43 days until earnings call
RAPT
Price
$20.96
Change
+$0.83 (+4.12%)
Updated
Sep 23 closing price
Capitalization
346.63M
Interact to see
Advertisement

CTMX vs RAPT

Header iconCTMX vs RAPT Comparison
Open Charts CTMX vs RAPTBanner chart's image
CytomX Therapeutics
Price$2.11
Change+$0.05 (+2.43%)
Volume$3.52M
Capitalization347.97M
RAPT Therapeutics
Price$20.96
Change+$0.83 (+4.12%)
Volume$102.24K
Capitalization346.63M
CTMX vs RAPT Comparison Chart in %
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. RAPT commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and RAPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (CTMX: $2.11 vs. RAPT: $20.96)
Brand notoriety: CTMX and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 119% vs. RAPT: 86%
Market capitalization -- CTMX: $347.97M vs. RAPT: $346.63M
CTMX [@Biotechnology] is valued at $347.97M. RAPT’s [@Biotechnology] market capitalization is $346.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 4 bearish.
  • RAPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CTMX and RAPT are a good buy in the short-term.

Price Growth

CTMX (@Biotechnology) experienced а +7.65% price change this week, while RAPT (@Biotechnology) price change was +18.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

CTMX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($348M) and RAPT($347M) have the same market capitalization . CTMX YTD gains are higher at: 104.854 vs. RAPT (65.823). CTMX has higher annual earnings (EBITDA): 44.7M vs. RAPT (-111.99M). RAPT has more cash in the bank: 169M vs. CTMX (158M). RAPT has less debt than CTMX: RAPT (3.16M) vs CTMX (6.89M). CTMX has higher revenues than RAPT: CTMX (141M) vs RAPT (0).
CTMXRAPTCTMX / RAPT
Capitalization348M347M100%
EBITDA44.7M-111.99M-40%
Gain YTD104.85465.823159%
P/E Ratio4.22N/A-
Revenue141M0-
Total Cash158M169M93%
Total Debt6.89M3.16M218%
FUNDAMENTALS RATINGS
CTMX vs RAPT: Fundamental Ratings
CTMX
RAPT
OUTLOOK RATING
1..100
7324
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
13100
PRICE GROWTH RATING
1..100
3735
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTMX's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for RAPT (77) in the null industry. This means that CTMX’s stock grew somewhat faster than RAPT’s over the last 12 months.

CTMX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RAPT (100) in the null industry. This means that CTMX’s stock grew similarly to RAPT’s over the last 12 months.

CTMX's SMR Rating (13) in the Biotechnology industry is significantly better than the same rating for RAPT (100) in the null industry. This means that CTMX’s stock grew significantly faster than RAPT’s over the last 12 months.

RAPT's Price Growth Rating (35) in the null industry is in the same range as CTMX (37) in the Biotechnology industry. This means that RAPT’s stock grew similarly to CTMX’s over the last 12 months.

CTMX's P/E Growth Rating (92) in the Biotechnology industry is in the same range as RAPT (100) in the null industry. This means that CTMX’s stock grew similarly to RAPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXRAPT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NETTF30.451.40
+4.83%
NetEase, Inc.
DTNOF1.50N/A
N/A
DNO ASA
BKUT513.80N/A
N/A
Bank of Utica (NY)
CTYP6.16N/A
N/A
Community Bankers (PA)
NGKSY18.02N/A
N/A
NITERRA CO LTD.

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
+2.43%
BCAB - CTMX
37%
Loosely correlated
-7.32%
RAPT - CTMX
34%
Loosely correlated
+4.12%
KZR - CTMX
34%
Loosely correlated
+1.83%
FATE - CTMX
33%
Loosely correlated
-3.95%
MDXG - CTMX
32%
Poorly correlated
-1.11%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with TRAW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+4.12%
TRAW - RAPT
45%
Loosely correlated
-1.57%
SLGL - RAPT
39%
Loosely correlated
+2.86%
CTMX - RAPT
35%
Loosely correlated
+2.43%
AVXL - RAPT
34%
Loosely correlated
-2.63%
PDSB - RAPT
32%
Poorly correlated
-2.78%
More